Gregory A Maglinte, PhD, MPH

BeOne Medicines Ltd

Poster(s):

• 1410 - Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia

• 1411 - Outcomes, inequities, and access to front-line preferred therapies for chronic lymphocytic leukemia in the United States: a real-world evidence study